Simplex Trading’s Tempest Therapeutics TPST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,571
Closed -$15K 9743
2025
Q1
$15K Buy
1,571
+116
+8% +$1.32K ﹤0.01% 6809
2024
Q4
$15K Buy
1,455
+449
+45% +$5.8K ﹤0.01% 6912
2024
Q3
$18K Buy
1,006
+989
+5,818% +$20.3K ﹤0.01% 6766
2024
Q2
$0 Sell
17
-2,892
-99% -$125K ﹤0.01% 9831
2024
Q1
$147K Sell
2,909
-2,278
-44% -$115K ﹤0.01% 5175
2023
Q4
$296K Buy
+5,187
New +$246K ﹤0.01% 4246
2021
Q1
Sell
-69
Closed -$27.9K 10043
2020
Q4
$28K Sell
69
-2
-3% -$691 ﹤0.01% 6726
2020
Q3
$22K Buy
71
+58
+446% +$19.7K ﹤0.01% 6306
2020
Q2
$4K Buy
+13
New +$5.19K ﹤0.01% 7075
2017
Q4
Hold
0
6694
2017
Q3
Hold
0
6648
2017
Q2
Hold
0
6800
2017
Q1
Sell
-1
Closed -$4.66K 5346
2016
Q4
$6K Buy
+1
New +$12.5K ﹤0.01% 4228
2016
Q2
Sell
-1
Closed -$22.8K 6459
2016
Q1
$28K Hold
1
﹤0.01% 2487
2015
Q4
$14K Sell
1
-1
-50% -$33K ﹤0.01% 3020
2015
Q3
$48K Buy
+2
New +$135K ﹤0.01% 2035
2015
Q2
Sell
-2
Closed -$183K 5863
2015
Q1
$181K Buy
+2
New +$266K 0.02% 768

Other funds holding TPST

Simplex Trading's TPST Position: Q2 2025 in Review

Simplex Trading sold out of Tempest Therapeutics (TPST) in Q2 2025, closing a stake of 1,571 shares — an estimated $15K sold.

Simplex Trading first reported a position in TPST in Q1 2015 and held it in 14 quarters. The position peaked at $296K in Q4 2023. 18 funds tracked by Wall St. Rank hold TPST as of Q2 2025.

  • Simplex Trading reported no remaining Tempest Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Simplex Trading sold 1,571 Tempest Therapeutics shares in Q2 2025, an estimated $15K.
  • Simplex Trading first reported a position in Tempest Therapeutics in Q1 2015 and held it in 14 quarters.
  • Simplex Trading's Tempest Therapeutics position peaked at $296K in Q4 2023.
  • 18 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2025.

Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.